Ayushman Kumar Banerjee With over 43 million COVID-19 cases having surfaced and more than 1.1 million deaths, researchers are relentlessly working round the clock to develop vaccines against the virus, SARS-CoV-2, which causes the COVID-19. This has led to a race for a vaccine against the novel coronavirus, and in this race, Moderna has devised […]
Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]
Prama Ghosh, Amity University Kolkata Severity and death from Coronavirus disease 2019 (Covid-19) are associated with the older population; testing such vaccine candidates is important to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A phase 1, open-label trial with an escalated dose of messenger RNA vaccine, mRNA-1273, which encodes the stabilized prefusion […]
